Skip to main content Accessibility help
×
Home
Hostname: page-component-78bd46657c-t6dlm Total loading time: 0.271 Render date: 2021-05-08T17:40:26.275Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": false, "newCiteModal": false, "newCitedByModal": true }

Tardive dyskinesia: motor system impairments, cognition and everyday functioning

Published online by Cambridge University Press:  07 September 2017

Martin Strassnig
Affiliation:
Department of Integrated Medical Science, Florida Atlantic University, Charles Schmidt College of Medicine, Boca Raton, Florida
Amie Rosenfeld
Affiliation:
Department of Integrated Medical Science, Florida Atlantic University, Charles Schmidt College of Medicine, Boca Raton, Florida
Philip D. Harvey
Affiliation:
Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida
Corresponding
E-mail address:

Abstract

The recent approval of treatments for tardive dyskinesia (TD) has rekindled interest in this chronic and previously recalcitrant condition. A large proportion of patients with chronic mental illness suffer from various degrees of TD. Even the newer antipsychotics constitute a liability for TD, and their liberal prescription might lead to emergence of new TD in patient populations previously less exposed to antipsychotics, such as those with depression, bipolar disorder, autism, or even attention deficit hyperactivity disorder. The association of TD with activity limitations remains poorly understood. We review potential new avenues of assessing the functional sequelae of TD, such as the performance of instrumental activities of daily living, residential status, and employment outcomes. We identify several mediating aspects, including physical performance measures and cognition, that may represent links between TD and everyday performance, as well as potential treatment targets.

Type
Review
Copyright
© Cambridge University Press 2017 

Access options

Get access to the full version of this content by using one of the access options below.

References

1. Haro, JM, Salvador-Carulla, L. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia. CNS Drugs. 2006; 20(4): 293301.CrossRefGoogle ScholarPubMed
2. Lerner, V, Miodownik, C. Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? a modern treatment. Curr Psychiatry Rep. 2011; 13(4): 295304.CrossRefGoogle ScholarPubMed
3. Merrill, RM, Lyon, JL, Matiaco, PM. Tardive and spontaneous dyskinesia incidence in the general population. BMC Psychiatry. 2013; 13: 152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681708/. Accessed August 11, 2019.CrossRefGoogle ScholarPubMed
4. Carbon, M, Hsieh, CH, Kane, JM, Correll, CU. Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J Clin Psychiatry. 2017; 78(3): e264e278.CrossRefGoogle ScholarPubMed
5. Correll, CU, Schenk, EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry. 2008; 21(2): 151156.CrossRefGoogle ScholarPubMed
6. Woods, SW, Morgenstern, H, Saksa, JR, et al. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. J Clin Psychiatry. 2010; 71(4): 463474.CrossRefGoogle ScholarPubMed
7. Kane, JM, Smith, JM. Tardive dyskinesia: prevalence and risk factors, 1959 to1979. Arch Gen Psychiatry. 1982; 39(4): 473481.CrossRefGoogle Scholar
8. Ganguli, R, Strassnig, M. Are older antipsychotic drugs obsolete? BMJ. 2006; 332(7554): 13461347.CrossRefGoogle ScholarPubMed
9. Crystal, S, Olfson, M, Huang, C, Pincus, H, Gerhard, T. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood). 2009; 28(5): w770w781.CrossRefGoogle ScholarPubMed
10. Monasterio, E, McKean, A. Quetiapine use: science or clever marketing? Aust N Z J Psychiatry. 2013; 47(1): 9697.CrossRefGoogle ScholarPubMed
11. Owens, DCG. A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge: Cambridge University Press; 1999.CrossRefGoogle Scholar
12. Casey, DE. Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiatry. 2000; 61(Suppl 4): 59.Google ScholarPubMed
13. Souza, R, Remington, G, Chowdhury, NI, et al. Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians. Eur Neuropsychopharmacol. 2009; 20(10): 688694.CrossRefGoogle Scholar
14. Lerner, PP, Miodownik, C, Lerner, V. Tardive dyskinesia (syndrome): current concept and modern approaches to its management. Psychiatry Clin Neurosci. 2015; 69(6): 321334.CrossRefGoogle ScholarPubMed
15. Bhidayasiri, R, Fahn, S, Weiner, WJ, et al. Evidence-based guideline: treatment of tardive syndromes. Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013; 81(5): 463469.CrossRefGoogle ScholarPubMed
16. Aia, PG, Revuelta, GJ, Cloud, LJ, Factor, SA. Tardive dyskinesia. Curr Treat Options Neurol. 2011; 13(3): 231241.CrossRefGoogle ScholarPubMed
17. Lieberman, JA, Saltz, BL, Johns, CA, Pollack, S, Borenstein, M, Kane, J. The effect of clozapine on tardive dyskinesia. Br J Psychiatry. 1999; 158: 503510.CrossRefGoogle Scholar
18. Welter, ML, Grabli, D, Vidailhet, M. Deep brain stimulation for hyperkinetics disorders; dystonia, tardive dyskinesia, and tics. Curr Opin Neurol. 2010; 23(4): 420425.Google ScholarPubMed
19. Kaur, N, Kumar, P, Jamwal, S, Deshmukh, R, Gauttam, V. Tetrabenazine: spotlight on drug review. Ann Neurosci. 2016; 23(3): 176185.CrossRefGoogle ScholarPubMed
20. Wimalasena, K. Vesicular monoamine transporters: structure–function, pharmacology, and medicinal chemistry. Med Res Rev. 2011; 31(4): 483519.CrossRefGoogle ScholarPubMed
21. Voelker, R. Tardive dyskinesia drug approved. JAMA. 2017; 317(19): 1942.Google ScholarPubMed
22. Citrome, L. Valbenazine for tardive dyskinesia: a systematic review of the efficacy and safety profile for this newly approved novel medication. What is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract. 2017; 71(7): doi: 10.1111/ijcp.12964. Epub ahead of print May 12.Google ScholarPubMed
23. Yassa, R, Jones, BD. Complications of tardive dyskinesia: a review. Psychosomatics. 1985; 26(4): 305313.CrossRefGoogle ScholarPubMed
24. Lohr, JB, Caliguri, MP. Quantitative instrumental measurement of tardive dyskinesia: a review. Neuropsychopharmacology.. 1993; 6(4): 231239.Google Scholar
25. Kuo, SH, Jankovic, J. Tardive gait. Clin Neurol Neurosurg. 2008; 110(2): 198201.CrossRefGoogle ScholarPubMed
26. Simpson, GM, Shrivastava, RK. Abnormal gaits in tardive dyskinesia. Am J Psychiatry. 1978; 135(7): 865.Google ScholarPubMed
27. Yassa, R. Functional impairment in tardive dyskinesia: medical and psychosocial dimensions. Acta Psychiatr Scand. 1989; 80(1): 6467.CrossRefGoogle ScholarPubMed
28. Lauterbach, EC, Singh, H, Simpson, GM, Morrison, RL. Gait disorders in tardive dyskinesia. Acta Psychiatr Scand. 1990; 82(3): 267.CrossRefGoogle ScholarPubMed
29. Montero-Odasso, M, Verghese, J, Beauchet, O, Hausdorff, JM. Gait and cognition: a complementary approach to understanding brain function and the risk of falling. J Am Geriatr Soc. 2012; 60(11): 21272136.CrossRefGoogle ScholarPubMed
30. Van Emmerik, RE, Sprague, RL, Newell, KM. Quantification of postural sway patterns in tardive dyskinesia. Mov Disord. 1993; 8(3): 305314.CrossRefGoogle ScholarPubMed
31. Ko, YG, Van Emmerik, RE, Sprague, RL, Newell, KM. Postural stability, tardive dyskinesia and developmental disability. J Intellect Disabil Res. 1992; 36(Pt 4): 309323.CrossRefGoogle ScholarPubMed
32. Leavy, B, Byberg, L, Michaëlsson, K, Melhus, H, Åberg, AC. The fall descriptions and health characteristics of older adults with hip fracture: a mixed methods study. BMC Geriatr. 2015; 15: 40. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428087/. Accessed August 11, 2017.CrossRefGoogle ScholarPubMed
33. Liu-Ambrose, T, Khan, KM, Donaldson, MG, Eng, JJ, Lord, SR, McKay, HA. Falls-related self-efficacy is independently associated with balance and mobility in older women with low bone mass. J Gerontol A Biol Sci Med Sci. 2006; 61(8): 832838.CrossRefGoogle ScholarPubMed
34. Blanchet, PJ, Rompre, PH, Lavinge, GJ, Lamarche, C. Oral dyskinesia: a clinical overview. Int J Prosthodont. 2005; 18(1): 1019.Google ScholarPubMed
35. Achiron, A, Melamed, E. Tardive eating dystonia. Mov Disord. 1990; 5(4): 331333.CrossRefGoogle ScholarPubMed
36. Girard, P, Monette, C, Normandeau, L, et al. Contribution of orodental status to the intensity of orofacial tardive dyskinesia: an interdisciplinary and video-based assessment. J Psychiatr Res. 2012; 46(5): 684687.CrossRefGoogle ScholarPubMed
37. Lumetti, S, Ghiacci, G, Macaluso, GM, et al. Tardive dyskinesia, oral parafunction, and implant-supported rehabilitation. Case Rep Dent. 2016. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5168480/. Accessed August 11, 2017.Google Scholar
38. Portnoy, RA. Hyperkinetic dysarthria as an early indicator of impending tardive dyskinesia. J Speech Hear Disord. 1979; 44(2): 214219.CrossRefGoogle ScholarPubMed
39. Myers, DE, Schooler, NR, Zullo, TG, Levin, H. A retrospective study of the effects of edentulism on the severity rating of tardive dyskinesia. J Prosthet Dent. 1993; 69(6): 578581.CrossRefGoogle ScholarPubMed
40. Samie, MR, Dannenhoffer, MA, Rozek, S. Life-threatening tardive dyskinesia caused by metroclopramide. Mov Disord. 1987; 2(2): 125129.CrossRefGoogle Scholar
41. Greenberg, DB, Murray, GB. Hyperventilation as a variant of tardive dyskinesia. J Clin Psychiatry. 1981; 42(10): 401403.Google ScholarPubMed
42. Chiang, E, Pitts, WM Jr, Rodriguez-Garcia, M. Respiratory dyskinesia: review and case reports. J Clin Psychiatry. 1985; 46(6): 232234.Google ScholarPubMed
43. Horiguchi, J, Shingu, T, Hayashi, T, et al. Antipsychotic-induced life-threatening “esophageal dyskinesia.”. Int Clin Psychopharm. 1999; 14(2): 123127.CrossRefGoogle Scholar
44. Clark, GT, Ram, S. Orofacial movement disorders. Oral Maxillofac Surg Clin North Am. 2016; 28(3): 397407.CrossRefGoogle ScholarPubMed
45. Caliguri, MP, Teulings, HL, Dean, CE, Lohr, JB. A quantitative measure of handwriting dysfluency for assessing tardive dyskinesia. J Clin Psychopharmacol. 2015; 35(2): 168174.CrossRefGoogle Scholar
46. Neelam, K, Garg, D, Marshall, M. A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia. BMC Psychiatry.. 2011; 11: 139. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173301/. Accessed August 11, 2017.CrossRefGoogle ScholarPubMed
47. Burton, BK, Hjorthøj, C, Jepsen, JR, Thorup, A, Nordentoft, M, Plessen, KJ. Research review: do motor deficits during development represent an endophenotype for schizophrenia? A meta-analysis. J Child Psychol Psychiatry. 2016; 57(4): 446456.CrossRefGoogle ScholarPubMed
48. Strassnig, M, Cornacchio, D, Harvey, PD, Kotov, R, Fochtmann, L, Bromet, EJ. Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder. J Psychiatr Res. 2017; 94: 180185.CrossRefGoogle ScholarPubMed
49. Vrtunski, PB, Alphs, LD, Meltzer, HY. Isometric force control in schizophrenia patients with tardive dyskinesia. Psychiatry Res. 1991; 37(1): 5772.CrossRefGoogle ScholarPubMed
50. Strassnig, M, Brar, JS, Ganguli, R. Low cardiorespiratory fitness and physical functional capacity in obese patients with schizophrenia. Schizophr Res. 2011; 126(1–3): 103109.CrossRefGoogle ScholarPubMed
51. Waddington, JL, O’Callaghan, E, Larkin, C, Kinsella, A. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia? Brain Cogn. 1993; 23(1): 5670.CrossRefGoogle ScholarPubMed
52. Waddington, JL, Youssef, HA, Dolphin, C, Kinsella, A. Cognitive dysfunction, negative symptoms, and tardive dyskinesia in schizophrenia: their association in relation to topography of involuntary movements and criterion of their abnormality. Arch Gen Psychiatry. 1987; 44(10): 907912.CrossRefGoogle ScholarPubMed
53. Waddington, JL, Youssef, HA, Kinsella, A. Cognitive dysfunction in schizophrenia followed up over 5 years, and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med. 1990; 20(4): 835842.CrossRefGoogle ScholarPubMed
54. Baribeau, J, Laurent, JP, Décary, A. Tardive dyskinesia and associated cognitive disorders: a convergent neuropsychological and neurophysiological approach. Brain Cogn. 1993; 23(1): 4055.CrossRefGoogle ScholarPubMed
55. Spohn, HE, Coyne, L. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics. Brain Cogn. 1993; 23(1): 2839.CrossRefGoogle ScholarPubMed
56. DeWolfe, AS, Ryan, JJ, Wolf, ME. Cognitive sequelae of tardive dyskinesia. J Nerv Ment Dis. 1988; 176(5): 270274.CrossRefGoogle ScholarPubMed
57. Byne, W, White, L, Parella, M, Adams, R, Harvey, PD, Davis, KL. Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment. Int J Geriatr Psychiatry. 1998; 13(7): 473479.3.0.CO;2-Z>CrossRefGoogle Scholar
58. Pourcher, E, Cohen, H, Cohen, D, Baruch, P, Bouchard, RH. Organic brain dysfunction and cognitive deficits in young schizophrenic patients with tardive dyskinesia. Brain Cogn. 1993; 23(1): 8187.CrossRefGoogle ScholarPubMed
59. Sachdev, P, Hume, F, Toohey, P, Doutney, C. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia. Acta Psychiatr Scand. 1996; 93(6): 451459.CrossRefGoogle ScholarPubMed
60. Struve, FA, Willner, AE. Cognitive dysfunction and tardive dyskinesia. Br J Psychiatry. 1983; 143: 597600.CrossRefGoogle ScholarPubMed
61. Wegner, JT, Kane, JM, Weinhold, P, Woerner, M, Kinon, B, Lieberman, J. Cognitive impairment in tardive dyskinesia. Psychiatry Res. 1985; 16(4): 331337.CrossRefGoogle ScholarPubMed
62. Wu, JQ, Chen, DC, Xiu, MH, et al. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 46: 7177.CrossRefGoogle Scholar
63. Krabbendam, L, van Harten, PN, Picus, I, Jolles, J. Tardive dyskinesia is associated with impaired retrieval from long-term memory: the Curaçao Extrapyramidal Syndromes Study: IV. Schizophr Res. 2000; 42(1): 4146.CrossRefGoogle ScholarPubMed
64. Miller, DD, McEvoy, JP, Davis, SM, et al. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial. Schizophr Res. 2005; 80(1): 3343.CrossRefGoogle ScholarPubMed
65. Sarro, S, Pomarol-Clotet, E, Canales-Rodriguez, EJ, et al. Structural brain changes associated with tardive dyskinesia in schizophrenia. Br J Psychiatry. 2013; 203(1): 5157.CrossRefGoogle Scholar
66. Pantelis, C, Stuart, GW, Nelson, HE, Robbins, TW, Barnes, TR. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms. Am J Psychiatry. 2001; 158(8): 12761285.CrossRefGoogle ScholarPubMed
67. Emsley, R, Niehaus, DJ, Oosthuizen, PP, Koen, L, Chiliza, B, Fincham, D. Subjective awareness of tardive dyskinesia and insight in schizophrenia. Eur Psychiatry. 2011; 26(5): 293296.CrossRefGoogle Scholar
68. Arango, C, Adami, H, Sherr, JD, Thaker, GK, Carpenter, WT Jr. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness. Am J Psychiatry. 1999; 156(7): 10971099.Google ScholarPubMed
69. Emsley, R, Niehaus, DJH, Oosthuizen, L, Koen, L, Chiliza, B, Fincham, D. Subjective awareness of tardive dyskinesia and insight in schizophrenia. Eur Psychiatry. 2011; 26(5): 293296.CrossRefGoogle Scholar
70. Myslobodsky, MS, Tomer, R, Holden, T, Kempler, S, Sigal, M. Cognitive impairment in patients with tardive dyskinesia. J Nerv Ment Dis. 1985; 173(3): 156160.CrossRefGoogle ScholarPubMed
71. Macpherson, R, Collis, R. Tardive dyskinesia. Patients’ lack of awareness of movement disorder. Br J Psychiatry. 1992; 160: 110112.CrossRefGoogle ScholarPubMed
72. Gould, F, McGuire, LS, Durand, D, et al. Self-assessment in schizophrenia: accuracy of evaluation of cognition and everyday functioning. Neuropsychology. 2015; 29(5): 675682.CrossRefGoogle ScholarPubMed
73. Meltzer, HY. Suicide in schizophrenia: risk factors and clozapine treatment. J Clin Psychiatry. 1998; 59(Suppl 3): 1520.Google ScholarPubMed
74. Hierholzer, RW. Tardive dyskinesia with complaints of pain. Am J Psychiatry. 1989; 146(6): 802.Google Scholar
75. Earle, J Jr, Patterson, WM. Chronic pain, neuroleptics, and tardive dyskinesia. Psychosomatics. 1986; 27(4): 291293.CrossRefGoogle ScholarPubMed
76. Blanchet, PJ, Popovici, R, Guitard, F, Rompré, PH, Lamarche, C, Lavigne, GJ. Pain and denture condition in edentulous orodyskinesia: comparisons with tardive dyskinesia and control subjects. Mov Disord. 2008; 23(13): 18371842.CrossRefGoogle ScholarPubMed
77. Schoonderwoerd, K. Chiropractic management of musculoskeletal pain secondary to tardive dyskinesia. J Can Chiropr Assoc. 2005; 49(2): 9295.Google ScholarPubMed
78. Jeste, DV, Caliguri, MP. Tardive dyskinesia. Schizophr Bull. 1993; 19(2): 303315.CrossRefGoogle ScholarPubMed
79. Strassnig, M, Signorile, J, Gonzalez, C, Harvey, PD. Physical performance and disability in schizophrenia. Schizophr Res Cogn. 2014; 1(2): 112121.CrossRefGoogle Scholar
80. Yassa, R. Functional impairment in tardive dyskinesia: medical and psychosocial dimensions. Acta Psychiatr Scand. 1989; 80(1): 6467.CrossRefGoogle ScholarPubMed
81. Dean, CE, Russell, JM, Kuskowski, MA, Caligiuri, MP, Nugent, SM. Clinical rating scales and instruments: how do they compare in assessing abnormal, involuntary movements? J Clin Psychopharmacol. 2004; 24(3): 298304.CrossRefGoogle ScholarPubMed

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Tardive dyskinesia: motor system impairments, cognition and everyday functioning
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Tardive dyskinesia: motor system impairments, cognition and everyday functioning
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Tardive dyskinesia: motor system impairments, cognition and everyday functioning
Available formats
×
×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *